Lisa Nolan - Net Worth and Insider Trading

Lisa Nolan Net Worth

The estimated net worth of Lisa Nolan is at least $3,265 dollars as of 2024-12-28. Lisa Nolan is the Chief Business Officer of Rexahn Pharmaceuticals Inc and owns about 451 shares of Rexahn Pharmaceuticals Inc (REXN) stock worth over $3,265. Details can be seen in Lisa Nolan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lisa Nolan has not made any transactions after 2019-01-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Lisa Nolan

To

Lisa Nolan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lisa Nolan owns 3 companies in total, including Rexahn Pharmaceuticals Inc (REXN) , Relmada Therapeutics Inc (RLMD) , and Opus Genetics Inc (IRD) .

Click here to see the complete history of Lisa Nolan’s form 4 insider trades.

Insider Ownership Summary of Lisa Nolan

Ticker Comapny Transaction Date Type of Owner
REXN Rexahn Pharmaceuticals Inc 2019-02-28 Chief Business Officer
RLMD Relmada Therapeutics Inc 2015-12-14 Chief Business Officer
IRD Opus Genetics Inc 2016-07-06 Chief Business Officer

Lisa Nolan Latest Holdings Summary

Lisa Nolan currently owns a total of 1 stock. Lisa Nolan owns 451 shares of Rexahn Pharmaceuticals Inc (REXN) as of January 30, 2019, with a value of $3,265.

Latest Holdings of Lisa Nolan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
REXN Rexahn Pharmaceuticals Inc 2019-01-30 451 7.24 3,265

Holding Weightings of Lisa Nolan


Lisa Nolan Form 4 Trading Tracker

According to the SEC Form 4 filings, Lisa Nolan has made a total of 0 transactions in Rexahn Pharmaceuticals Inc (REXN) over the past 5 years. The most-recent trade in Rexahn Pharmaceuticals Inc is the acquisition of 417 shares on January 30, 2019, which cost Lisa Nolan around $13,000.

Insider Trading History of Lisa Nolan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Lisa Nolan Trading Performance

GuruFocus tracks the stock performance after each of Lisa Nolan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lisa Nolan is -21.3%. GuruFocus also compares Lisa Nolan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lisa Nolan within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Lisa Nolan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Lisa Nolan

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -16.83 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -21.4 LIMIT LIMIT LIMIT LIMIT LIMIT

Lisa Nolan Ownership Network

Ownership Network List of Lisa Nolan

No Data

Ownership Network Relation of Lisa Nolan

Insider Network Chart

Lisa Nolan Owned Company Details

What does Rexahn Pharmaceuticals Inc do?

Who are the key executives at Rexahn Pharmaceuticals Inc?

Lisa Nolan is the Chief Business Officer of Rexahn Pharmaceuticals Inc. Other key executives at Rexahn Pharmaceuticals Inc include Chief Medical Officer Ely Benaim , director & President and CEO Douglas J Swirsky , and director & Chief Executive Officer Peter David Suzdak .

Rexahn Pharmaceuticals Inc (REXN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Rexahn Pharmaceuticals Inc (REXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rexahn Pharmaceuticals Inc (REXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Rexahn Pharmaceuticals Inc (REXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Rexahn Pharmaceuticals Inc Insider Transactions

No Available Data

Lisa Nolan Mailing Address

Above is the net worth, insider trading, and ownership report for Lisa Nolan. You might contact Lisa Nolan via mailing address: 36 Rockland Mills, Rockland De 19732.

Discussions on Lisa Nolan

No discussions yet.